Market research reports on: Pharmaceutical manufacture, cancer, oncology, prevention and treatment, therapeutics, vaccines, clinical studies, drug delivery, immunology, immunotherapy and others.
Let's ConnectIdiopathic Pulmonary Fibrosis Disease Treatment: Global Markets
This report provides an overview of the idiopathic pulmonary fibrosis (IPF). It outlines perspective on the drugs and therapies used for the management of IPF, including forecast trends and sales through 2024. Important manufacturers, technologies and factors influencing demand are discussed.
Global Markets for Treatment and Diagnosis of Sexually Transmitte...
The global market for sexually transmitted disease diagnostics should grow from $7.6 billion in 2020 to $10.6 billion by 2025 at compound annual growth rate (CAGR) of 7.0% for the period of 2020-2025.
Phenylketonuria Treatment Market: A BCC Research Perspective
The goals of this study were to understand the current market scenario for the treatment options of phenylketonuria (PKU) which includes food for medical purposes (FSMPs), and to assess the market’s growth potential through the end of 2025. This study explores market dynamics such as drivers, restraints, opportunities, and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current treatment market for phenylketonuria and the future directions of the market.
Acne Drugs: Global Markets
The global acne drugs market should reach $7.9 billion by 2025 from $5.9 billion in 2020 at a compound annual growth rate (CAGR) of 5.7% for the forecast years, 2020 to 2025.
Outsourcing Market for Drug and Medical Device Development: Servi...
The global outsourcing services market for drug and medical device development is expected to grow from 130.5 billion pounds in 2020 to 205.6 billion pounds by 2025 with a compound annual growth rate (CAGR) of 9.5% for the period of 2020-2025.
Cannabidiol (CBD) Oil: Global Markets
The global market for cannabidiol (CBD) oil should grow from $967.2 million in 2020 to $5.3 billion by 2025, at compound annual growth rate (CAGR) of 40.4% for the period of 2020-2025.
Pharmaceuticals for Women's Health: Global Markets
The global market for women’s health therapeutics should grow from $31.5 billion in 2019 to $41.2 billion by 2025, at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2025.
Pharmaceutical Pricing and Reimbursement: Global Markets
The global pharmaceuticals market was valued at $1,058 billion in 2019 and should reach $1,520 billion by 2024 with a compound annual growth rate (CAGR) of 7.5% from 2019 to 2024.
Global Market for Pain Management Patches
The global market for pain management patches should grow from $4.2 billion in 2018 to $5.3 billion by 2023, at a compound annual growth rate (CAGR) of 4.5% for the period of 2018-2023.
Pandemic Outbreaks in the Past Decade: A BCC Research Overview
This report focuses on epidemiology, research and development, current treatment and diagnostics and global response to selected pandemics of the past decade (2009-2020). The report discusses lessons learned from previous outbreaks in terms of policies and measures of prevention and control.
Health Technology Assessment in Pharma: A Review of Major Decisio...
The goal of this study is to provide information on the global health technology approval process in North America, Europe and the Asia-Pacific region. The study emphasizes the role of HTA and its function and technology process in the pharmaceutical industry. The report also elaborates on recent HTA approvals and their significance on pricing and reimbursement.
Hyperkalemia Market: A BCC Research Perspective
The hyperkalemia market is currently a flourishing market, with a strong drug pipeline and upcoming technologies for the diagnosis of conditions. This report on Hyperkalemia Market highlights market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. BCC Research focuses on the comprehensive analysis of the current market for hyperkalemia and the future direction of the market.
Medical Affairs: The Roadmap to 2025
This report on Medical Affairs highlights overall growth due to rapidly changing pharmaceutical and medical device markets by forming new paradigms and employing marketing strategies that increase market share. The research will provide information on leading market competitors, their market share, partnerships, collaborations, mergers and acquisitions between pharmaceutical companies. BCC Research focuses on the importance of medical affairs in communicating and collecting the medical evidence with the organization and external stakeholders.
Bioinks: The Living Foundation of Functional Bioprinting
The goal of this short study is to help companies operating within the life science sector gain valuable insights on bioinks by providing an overview of types, compositions, and applications of bioinks. This report outlines the trends that are expected to contribute to market growth for these materials.
Non-injectable Insulin
This comprehensive report provides an in-depth assessment of the global market for non-injectable insulin. The report's key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of non-injectable insulin in developed and emerging markets.
Top 5 Generic Opportunities in Pharmaceuticals to Watch in 2019: ...
In the context of the huge impact of generic drug development and its implication in cost savings, an attempt has been made to analyze various pharmaceutical original products which experience patent expiry and likely to go off patents. The report also covers a section illustrating the case for development and opportunities that lie for manufacturers engaged in the generic or biosimilar business for the key drugs.
ROI in Pharmaceutical R&D: How to Halt the Decline
This report is designed to investigate recent years of performance of pharmaceutical and biopharmaceutical companies with respect to return on investment (ROI) in research and development (R&D), and to discuss ways that companies are trying to improve ROI through 2024. Investigation will include Country/Regional market trends with top areas of return, 2014-2024. This report also looks at which companies are already using artificial intelligence (AI) and machine learning (ML) to successfully compete globally.
Pediatric Medicines: Global Markets
The global pediatric market should grow from $92.6 billion in 2019 to reach $116.6 billion by 2024 at a compound annual growth rate (CAGR) of 4.7% for the period of 2019-2024.
Cannabis Market: Products, Technologies and Applications
The global cannabis market should grow from $25.6 billion in 2019 to $77.6 billion by 2024 at a compound annual growth rate (CAGR) of 24.8% for the period of 2019-2024.
Over-the-Counter (OTC) Drugs and Dietary Supplements: Opportuniti...
This report on Over-the-Counter (OTC) drugs and dietary supplement products market highlights primary healthcare and its various parameters such as the drafting of rules and regulations for OTC drugs and dietary supplements, the number of drugs classified, self-care awareness among consumers and the size of distribution networks, OTC drugs and dietary supplements manufacturers. BCC Research analyzed key categories and regions to determine the present and future OTC drugs and dietary supplement products market status and forecasted market growth.
Significant Drug Launches in 2019: A BCC Research Analysis and In...
This report provides information on significant drug launches in 2019. The study provides an overview of each drug, scientific summaries, pharmacodynamics, pharmacokinetics and clinical trial information, disease backgrounds, analysis of the market, competitors and company profiles of manufacturers. The objective of this study is to present a comprehensive analysis of the current market and its future direction.
Communicable Disease Market: A BCC Research Overview
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.8% for the period of 2019-2024.
Continuous Manufacturing in Pharmaceuticals: Implications for the...
This report presents a perspective on the adoption of continuous manufacturing technologies by pharmaceuticals, the role of the FDA and implications for the generics sector.
Interleukin-2, a Tale of Two Halves: To Suppress or Augment Suppr...
The report provides a detailed description of autoimmune responses and possible ways that drug development can augment immune responses so as to improve antitumor activity and reduce off target effect.This report will assess the latest developments in the IL-2 research and development and explore the novel strategies companies are adopting to augment immune response and avoid off target effects in a wide range of conditions including, metastatic melanoma (MM), renal cell carcinoma (RCC), urothelial cancers (US) relapse remitting multiple sclerosis (RRMS), Type 1 diabetes (T1D), as a prophylaxis post-transplant and allergic conditions.What's coming: There are more than 200 studies underway evaluating IL-2 based therapies either as a monotherapy or in combination. The key products and companies that we believe are worth watching in this space are summarized.
Markets at a Glance: Pharmaceuticals
The “Market at a Glance Pharmaceuticals” provides an access to all the market share analysis segments of the best-selling and key pharmaceutical reports of BCC Research. This report is a destination for the competitive landscape in the markets that hold a significant stand in the pharmaceuticals sector. Company profiles for all the notable manufacturers in the global pharmaceutical industry are provided as a part of this report.
Cannabis Market: Products, Technologies, and Applications
This report provides an overview of the global cannabis market and analyzes market trends. It focuses on the significant driving trends and challenges that affect the market and vendor landscape.
Monoclonal Antibodies for Oncology: Global Markets
This report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market’s drivers, challenges, and opportunities. The report also covers market projections to 2030 and market share for key market players.
Global Bispecific Antibodies Market
This report provides an overview of the global bispecific antibodies market and analyzes market trends. It includes global revenue ($ million) for the base year data of 2024 and estimated data for the forecast period from 2025 through 2030.
Cardiovascular Drugs: Global Markets to 2030
This report provides detailed exposure of the cardiovascular drugs market, highlighting major cardiovascular diseases with detailed epidemiology for the primary disease areas. It includes an industrywide assessment of the novel product launches, recent approvals, R&D pipeline and blockbuster drugs.
Lung Cancer Therapeutics: Global Markets
This report will provide detailed information on the global market for lung cancer therapeutics. This report analyzes the market trends of lung cancer therapeutics with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030, and regional markets of lung cancer therapeutics.
Radioligand Therapeutics in Cancer Treatment: Global Market
This report provides an analysis of radioligand therapeutics in cancer treatment market along with detailed profiles of key market players including a revenue product portfolio and recent activities. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030.
Neuroprotective Agents: Therapeutic Applications and Global Markets
This report provides an overview of the global market for neuroprotective agents and their therapeutic applications. It includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the forecast period 2026 through 2030.
Emerging Drugs: Global Markets
The report provides an overview of the global emerging drugs and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030. The market is based on molecule type, product type, therapeutic application, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on major countries in these regions.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social, and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key players in the global Emerging Drugs Market. It also has a dedicated section of company profiles that covers details of leading key market players.
Substance Abuse and Addiction Treatment: Global Markets to 2030
This report presents an in-depth analysis of the global substance abuse and addiction treatment market. It provides market analyses by conditions, treatments, and geographic regions. The report includes the principal drug abuse conditions that are incorporated into several therapeutic treatment methods.
In Vitro Toxicity Testing: Technologies and Global Markets
This report provides an overview of the global in vitro toxicity testing market and analyzes market trends. It includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.
